US › Healthcare

CalciMedica, Inc. Common Stock (CALC)

US · Healthcare · Biotechnology

$0.80+5.62%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$5.0M
Profit YoY
+198.7%
EPS
$0.30
EPS estimate
$-0.28

EPS came in at 0.30 against a street estimate of -0.28 — a beat of 207.1%.

Key statistics

Market cap
$11.7M
Forward P/E
0.0
P/B
6.98
Book value
$-0.07
EPS (TTM)
$-1.36
52-week high
$7.20
52-week low
$0.46
50-day MA
$0.81
200-day MA
$2.06
Beta
1.11

Analyst view

Analysts rate CalciMedica, Inc. Common Stock a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $10.50.

Shareholding

Insiders
20.58%
Institutions
34.13%

Largest institutional holders

FundStake
Vanguard Group Inc2.58%
Jane Street Group LLC1.13%
Vanguard Capital Management, LLC1.07%
Renaissance Technologies Corp0.81%
Geode Capital Management, LLC0.78%
180 WEALTH ADVISORS, LLC0.53%
Meritage Portfolio Management0.39%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.0.38%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for CalciMedica, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.